Mawuena Binka: School of Population and Public Health, University of British Columbia, Canada
Dr Mawuena Binka is a Research Scientist at the School of Population and Public Health at University of British Columbia, and is based at the British Columbia Centre for Disease Control in Vancouver, Canada. Her research is focused on the epidemiology of infectious diseases, with particular emphasis on hepatitis B, hepatitis C, HIV, and SARS-CoV-2 infections. She is passionate about the use of health administrative data to address inequities in health service delivery and health outcomes, especially among marginalized populations.
Antony P. Black: Institut Pasteur du Laos, Laos
Dr Antony Black is the head of the vaccine-preventable diseases research group at the Institut Pasteur du Laos in Vientiane. His group’s research focuses on vaccines and infectious diseases and there is a strong interdisciplinary approach, with integrated public health investigations. Viral hepatitis research is a major activity within the group, including the epidemiology of infections in vulnerable Lao populations.
Zahid Ahmad Butt: School of Public Health Sciences, University of Waterloo, Canada
Dr Zahid Butt is a physician epidemiologist with over 20 years of public health experience. He is an Assistant professor in the School of Public Health Sciences at the University of Waterloo. His research focuses on HCV, HBV and HIV epidemiology and disease mapping and applies a ‘syndemic’ framework to examine relationships between infectious diseases (HIV, HBV, HCV, COVID-19), social determinants of health and substance use. He is an associate editor for BMC Public Health.
Jack Wallace: Burnet Institute, Australia
Dr Jack Wallace investigates viral hepatitis as an issue where the biomedical, social, economic and political intersect, and where he privileges the social, cultural and lived experience of people with the infection over that of clinical understandings. While his work is informed by his own experience of living with hepatitis C, he seeks to understand how the health system can better respond to the needs of people with viral hepatitis, particularly people with hepatitis B born in, and/or living in the Asia Pacific region.
